Physiomics Plc (LON:PYC – Get Free Report)’s share price was up 21.3% on Wednesday . The company traded as high as GBX 1.19 ($0.01) and last traded at GBX 1 ($0.01). Approximately 5,343,470 shares changed hands during trading, a decline of 23% from the average daily volume of 6,964,461 shares. The stock had previously closed at GBX 0.83 ($0.01).
Physiomics Stock Performance
The firm has a market cap of £2.18 million, a price-to-earnings ratio of -13.83 and a beta of 1.69. The firm’s 50 day moving average is GBX 0.74 and its 200-day moving average is GBX 0.71.
Insider Buying and Selling at Physiomics
In related news, insider Peter Sargent purchased 459,090 shares of the stock in a transaction on Thursday, November 7th. The shares were bought at an average price of GBX 1 ($0.01) per share, for a total transaction of £4,590.90 ($5,660.09). Corporate insiders own 4.18% of the company’s stock.
Physiomics Company Profile
Physiomics Plc provides consulting services to pharmaceutical companies in the areas of outsourced quantitative pharmacology and computational biology in the United Kingdom, the United States, and the European Union Switzerland. The company offers modeling, simulation, and data analysis services covering various ranges of oncology research and development using its proprietary Virtual Tumour predictive software.
See Also
- Five stocks we like better than Physiomics
- What Are the FAANG Stocks and Are They Good Investments?
- SAP’s Strong Momentum: A Bullish Setup for Investors
- Stock Dividend Cuts Happen Are You Ready?
- BlackRock Breaks Records: Why the Stock Still Has Room to Run
- What is the Shanghai Stock Exchange Composite Index?
- Duke vs. NRG: Which Energy Stock Will Power Higher Gains?
Receive News & Ratings for Physiomics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Physiomics and related companies with MarketBeat.com's FREE daily email newsletter.
